These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30130800)

  • 1. Clinical and Economic Impact of Adopting Noninvasive Prenatal Testing as a Primary Screening Method for Fetal Aneuploidies in the General Pregnancy Population.
    Kostenko E; Chantraine F; Vandeweyer K; Schmid M; Lefevre A; Hertz D; Zelle L; Bartha JL; Di Renzo GC
    Fetal Diagn Ther; 2019; 45(6):413-423. PubMed ID: 30130800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
    Xie X; Wang M; Goh ES; Ungar WJ; Little J; Carroll JC; Okun N; Huang T; Rousseau F; Dougan SD; Tu HA; Higgins C; Holubowich C; Sikich N; Dhalla IA; Ng V
    J Obstet Gynaecol Can; 2020 Jun; 42(6):740-749.e12. PubMed ID: 32008974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
    Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
    PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis.
    Nshimyumukiza L; Beaumont JA; Duplantie J; Langlois S; Little J; Audibert F; McCabe C; Gekas J; Giguère Y; Gagné C; Reinharz D; Rousseau F
    J Obstet Gynaecol Can; 2018 Jan; 40(1):48-60. PubMed ID: 28784564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome of autosomal aneuploidies other than common trisomies detected by noninvasive prenatal testing in routine clinical practice.
    Wan J; Li R; Zhang Y; Jing X; Yu Q; Li F; Li Y; Zhang L; Yi C; Li J; Li D; Liao C
    Prenat Diagn; 2018 Oct; 38(11):849-857. PubMed ID: 30078205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal testing.
    Lo JO; Cori D F; Norton ME; Caughey AB
    Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application and evaluation of health economics for non-invasive prenatal testing of fetuses in Tianjin].
    Ma R; Li X; Xu S; Shi Y; Ju D; Li Y; Meng F; Wang X; Du X; Xu N; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):135-142. PubMed ID: 36709929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population.
    Benn P; Curnow KJ; Chapman S; Michalopoulos SN; Hornberger J; Rabinowitz M
    PLoS One; 2015; 10(7):e0132313. PubMed ID: 26158465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.
    Zhang W; Mohammadi T; Sou J; Anis AH
    PLoS One; 2019; 14(12):e0225281. PubMed ID: 31800591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective and cost-effective analysis of the result of Changsha Municipal Public Welfare Program by Noninvasive Prenatal Testing].
    Wang D; He J; Ma Y; Xi H; Zhang M; Huang H; Rao L; Zhang B; Mi C; Zhou B; Liao Z; Dai L; Ouyang X; Zhang Y; Wang H; Wang X; Zhang Z; Yao S; Tan Z; Yang J; Zhong W; Wang N; Liu J; Zhou L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Mar; 39(3):257-263. PubMed ID: 35315032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness Analysis of Non-invasive Prenatal Testing for Down Syndrome in China.
    Xu Y; Wei Y; Ming J; Li N; Xu N; Pong RW; Chen Y
    Int J Technol Assess Health Care; 2019 Jan; 35(3):237-242. PubMed ID: 31131776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: A systematic review of economic evaluations.
    Nshimyumukiza L; Menon S; Hina H; Rousseau F; Reinharz D
    Clin Genet; 2018 Jul; 94(1):3-21. PubMed ID: 29030960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.
    Noh JJ; Ryu HM; Oh SY; Choi SJ; Roh CR; Kim JH
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):545-551. PubMed ID: 31307749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.